Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study ✰
Titel:
Trifluridine/tipiracil plus bevacizumab in patients with untreated metastatic colorectal cancer ineligible for intensive therapy: the randomized TASCO1 study ✰
Auteur:
Van Cutsem, E. Danielewicz, I. Saunders, M.P. Pfeiffer, P. Argilés, G. Borg, C. Glynne-Jones, R. Punt, C.J.A. Van de Wouw, A.J. Fedyanin, M. Stroyakovskiy, D. Kroening, H. Garcia-Alfonso, P. Wasan, H. Falcone, A. Kanehisa, A. Egorov, A. Aubel, P. Amellal, N. Moiseenko, V.